GLP-3(Retatrutide)

PepXClub Verified independent store

→

Retatrutide (LY3437943) is a novel triple-agonist peptide that simultaneously targets GLP-1, GIP, and glucagon receptors. This triple mechanism produces synergistic metabolic effec ts beyond single or dual agonists. Phase 2 clinical trials have demonstrated significant results in metabolic research, making it one of the most studied multi-receptor agonists. Show more